Do you want to read an article? Please log in or register.
Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading
Ocular Oncology
Related content
Ocular Oncology
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
Eur J Cancer.
Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C
doi: 10.1016/j.ejca.2017.05.038.
Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study
Br J Dermatol.
Laino AM, Berry EG, Jagirdar K, Lee KJ, Duffy DL, Soyer HP, Sturm RA
doi: 10.1111/bjd.16323.
Ocular Oncology
Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients
Clin Exp Ophthalmol.
Yang X, Dalvin LA, Mazloumi M, Chang M, Shields JA, Mashayekhi A, Shields CL
doi: 10.1111/ceo.13758.
COMMENTED
Ocular Oncology
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1001/jamaophthalmol.2019.5132.
Macular DiseasesOcular OncologyRetinal Diseases
Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients
Br J Ophthalmol.
Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, Shields CL
doi: 10.1136/bjophthalmol-2019-314686.
Uveitis
Population-based frequency of ophthalmic adverse events in melanoma, other cancers, and after immune checkpoint inhibitor treatment
Am J Ophthalmol
Braun D, Getahun D, Chiu VY, Coleman AL, Holland GN, Yu F, Gordon LK, Sun MM
doi: 10.1016/j.ajo.2020.12.013
Surgery and Intervention
Association of Intravitreal Injections With Blood Pressure Increase: The Following Excitement and Anxiety Response Under Intravitreal Injection Study
JAMA Ophthalmol.
Berger V, Munk MR, Lersch F, Wolf S, Ebneter A, Zinkernagel MS
doi: 10.1001/jamaophthalmol.
Ocular OncologyFurther Publications
Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options
Prog Retin Eye Res
Brouwer NJ, Verdijk RM, Heegaard S, Marinkovic M, Esmaeli B, Jager MJ
doi: 10.1016/j.preteyeres.2021.100971
Ocular Oncology
Managing patients with choroidal melanoma in the COVID-19 era: a personal perspective
No abstract available